Wednesday, May 15, 2024

AstraZeneca Withdrawing Covid Vaccine Worldwide, Months After Admitting Rare Side Effect; AstraZeneca Admits for First Time Its Covid Vaccine CAN Cause Rare Side Effect in Tense Legal Fight With Victims of 'defective' Jab, and other C-Virus related stories

AstraZeneca withdrawing Covid vaccine, months after admitting rare side effect:
The Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, months after the pharmaceutical giant admitted for the first time in court documents that it can cause a rare and dangerous side effect.
The vaccine can no longer be used in the European Union, after the company voluntarily withdrew its “marketing authorisation”. The application to withdraw the vaccine was made on March 5 and came into effect on Tuesday.
Similar applications will be made in the coming months in the UK and in other countries that had approved the vaccine, known as Vaxzevria.
The decision to withdraw it brings to an end the use of the jab, which was heralded by Boris Johnson as a “triumph for British science” and credited with saving more than six million lives.
AstraZeneca said the vaccine was being removed from markets for commercial reasons. It said the vaccine was no longer being manufactured or supplied, having been superseded by updated vaccines that tackle new variants.
Vaxzevria has come under intense scrutiny in recent months over a very rare side effect, which causes blood clots and low blood platelet counts. AstraZeneca admitted in court documents lodged with the High Court in February that the vaccine “can, in very rare cases, cause TTS”.
TTS – which stands for Thrombosis with Thrombocytopenia Syndrome – has been linked to at least 81 deaths in the UK as well as hundreds of serious injuries. AstraZeneca is being sued by more than 50 alleged victims and grieving relatives in a High Court case.
But Astrazeneca has insisted the decision to withdraw the vaccine is not linked to the court case or its admission that it can cause TTS. It said the timing was pure coincidence.
In a statement the company said: “We are incredibly proud of the role Vaxzevria played in ending the global pandemic. According to independent estimates, over 6.5 million lives were saved in the first year of use alone and over three billion doses were supplied globally.
“Our efforts have been recognised by governments around the world and are widely regarded as being a critical component of ending the global pandemic. --->READ MORE HERE
AstraZeneca admits for first time its Covid vaccine CAN cause rare side effect in tense legal fight with victims of 'defective' jab:
AstraZeneca has admitted in court for the first time that its Covid jab can cause a deadly blood clotting side effect.
The exceedingly rare reaction is at the heart of a multi million-pound class action by dozens of families who allege they, or their loved ones, were maimed or killed by the pharmaceutical titan's 'defective' vaccine.
Lawyers representing the claimants believe some of the cases could be worth up to £20m in compensation.
Cambridge-based AstraZeneca, which is contesting the claims, acknowledged in a legal document submitted to the High Court in February that its vaccine 'can, in very rare cases, cause TTS'.
TTS is short for thrombosis with thrombocytopenia syndrome – a medical condition where a person suffers blood clots along with a low platelet count. Platelets typically help the blood to clot.
The complication – listed as a potential side effect of the jab – has previously been called vaccine-induced immune thrombotic thrombocytopenia (VITT).
AstraZeneca's admission could lead to pay-outs on a case-by-case basis.
Although accepted as a potential side effect for two years, it marks the first time the company has admitted in court that its jab can cause the condition, The Telegraph reports.
Taxpayers will foot the bill of any potential settlement because of an indemnity deal AstraZeneca struck with the Government in the darkest days of Covid to get the jabs produced as quickly as possible while the country was paralysed by lockdowns.
It comes just days after the firm reported a revenue exceeding £10billion in the first quarter of 2024, a rise of 19 per cent. Company officials stated it had enjoyed a 'very strong start' to the year.
One of those seeking compensation for injuries linked to AstraZeneca's vaccine is father-of-two and IT engineer Jamie Scott.
He was left with a permanent brain injury following a blood clot and the bleed on the brain after getting the vaccine in April 2021. He has been unable to work since.
His is one of 51 cases currently lodged in the High Court seeking damages estimated to be worth about £100million in total. --->READ MORE HERE
Follow links below to relevant/related stories and resources:

As Covid-19 emergency funding dries up, some rural schools may face a steep fiscal cliff in 2024

FLiRT COVID-19 Variants Are Spreading: What to Know About KP.2 and KP.1.1 Strains

USA TODAY: Coronavirus Updates

WSJ: Coronavirus Live Updates

YAHOO NEWS: Coronavirus Live Updates

NEW YORK POST: Coronavirus The Latest

If you like what you see, please "Like" and/or Follow us on FACEBOOK here, GETTR here, and TWITTER here.

No comments: